GENE ONLINE|News &
Opinion
Blog

Phase 3 Trial
R&D Alzheimer's Disease
Alzheon’s Bags $47 Million from NIA for Oral Alzheimer’s Drug
2020-08-22
COVID-19 Vaccine
COVID-19 Vaccine: Russia Announces Approval of “Sputnik V” Despite Concerns Over Safety
2020-08-12
Trials & Approvals Pancreatic Cancer
Lynparza Notches EU Authorization for BRCA-Mutated Metastatic Pancreatic Cancer
2020-07-11
Trials & Approvals Bladder Cancer
Bavencio Bags FDA Approval as First-line Maintenance Treatment for Urothelial Carcinoma
2020-07-05
Trials & Approvals
With NASH Drug Rejected, Intercept CEO Lambasts FDA’s Evolving Guidelines
2020-07-01
Hemophilia B
CSL Behring to Tackle Hemophilia B Using UniQure’s Gene Therapy Program
2020-06-28
Trials & Approvals Pneumococcal Vaccine
Merck’s Pneumonia Vaccine Candidate Blossoms in Phase 3 Trial
2020-06-28
Trials & Approvals Pneumonia
FDA Okays Merck ‘s Combination Antibiotic for Hospital-Acquired Bacterial Pneumonia
2020-06-12
Trials & Approvals RNAi Therapeutics
Alnylam’s RNAi-Based Therapy Lumasiran Impresses in Phase 3 Primary Hyperoxaluria Trials
2020-06-12
Trials & Approvals Axial Spondyloarthritis
Novartis’ Axial Spondyloarthritis Drug, Cosentyx Shines in Phase 3 Study
2020-06-08
COVID-19 Remdesivir
Remdesivir Registers Middling Benefit in Patients with Moderate COVID-19
2020-06-01
R&D
ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
2020-05-29
Trials & Approvals Breast Cancer
Novartis’ Kisqali Shows Promising Results in Advanced Breast Cancer Patients with Liver Metastases
2020-05-28
Trials & Approvals Prostate Cancer
Lynparza Greenlighted by FDA for HRR-Mutated, Metastatic Prostate Cancer
2020-05-27
R&D Multiple Sclerosis
Novartis Announces Mayzent Data that Shows Extended Benefit in Secondary Progressive MS
2020-04-21
1 2 3 4 5 6
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top